Germany-based LANXESS is undergoing a sale process for its water treatment business which comprises ion exchange resins and reverse osmosis (RO) membranes, sources in the financial community said.
“There’s an intermediate round going on right now where several bidders have been selected make indicatory bids,” said a source.
“Both strategics and private equity are interested and it appears to be a very competitive process,” he added.
A LANXESS spokesperson said the company does not comment on market rumours.
LANXESS is targeting a valuation in the double-digit EBITDA (earnings before interest, tax, depreciation and amortisation) range, shutting out certain private equity players, a source noted.
Sales of the water treatment business are about €210m, with EBITDA of around €35m, a source said.
“It smells like a strategic deal,” a source said.
Teasers on the sale went out in late February to early March, and the process is currently “passing round 1B, which is before any due diligence”, a source said.
LANXESS’ water treatment business is its Liquid Purification Technologies (LPT) business unit which sits its Performance Chemicals segment. LPT produces ion exchange resins as well as RO membranes.
Bank of America is running the sales process, a source said. Bank of America could not be immediately reached for comment.
By Joseph Chang
Source: ICIS News
Elastomers are special polymers with high elasticity. Affinity RE is one of the first bio-based, high-performance polyolefin elastomers on the market, Dow indicates.
OMV AG (Vienna, Austria) and Kommunalkredit Austria AG (Kommunalkredit) have announced a joint investment in the construction of Austria’s largest electrolysis plant in the OMV Schwechat Refinery.
U.S. chemicals maker Dow Inc has put German infrastructure assets up for sale in a potential 800 million euro ($966 million) deal as it seeks cash for investment elsewhere, sources close to the matter told Reuters.